The Ethical and Legal Implications of Deactivating an Implantable Cardioverter-Defibrillator in a Patient With Terminal Cancer
Journal of Medical Ethics 2007 September; 33(9): 538-540
In this paper, the ethical and legal issues raised by the deactivation of implantable cardioverter- defibrillators (ICDs) in patients with terminal cancer is considered. It is argued that the ICD cannot be well described either as a treatment or as a non-treatment option, and thus raises complex questions regarding how rules governing deactivation should be framed. A new category called "integral devices" is proposed. Integral devices require their own special rules, reflecting their position as a "halfway house" between a form of treatment and a part of the body. The practical problems faced by doctors working in palliative medicine with regard to the deactivation of ICDs are also considered.
Showing items related by title, author, creator and subject.
Causes and Consequences of Discontinuation of the Implantable Cardioverter-Defibrillator Therapy in Non-Terminally Ill Patients Li, Huagui; Natale, Andrea; Zhu, Weixi; Greenfield, Ruth Ann; Easley, Arthur; Barrington, William; Windle, John (1998-05-15)
Paola, Frederick A.; Walker, Robert M. (2000-01)
Perspectives on Withdrawing Pacemaker and Implantable Cardioverter-Defibrillator Therapies at End of Life: Results of a Survey of Medical and Legal Professionals and Patients Kapa, Suraj; Mueller, Paul S; Hayes, David L; Asirvatham, Samuel J (2010-11)To determine the opinions of medical professionals, legal professionals, and patients regarding the withdrawal of implantable cardioverter-defibrillator (ICD) and pacemaker therapy at the end of life.